VIE •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/29/2026 11:07
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeVIE
Market Capitalization172,437 mln
Float538 mln
Earnings Date08/04/2026
EPS
12.63
Robust
P / E
27.45
Elevated
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.61
Likely reliable
Relative Strength
92
/ 100
Top performer
Debt / Equity
6.24
Extremely leveraged
Business Description
Amgen is a global biotechnology company focused on researching, producing, and delivering medicines that treat serious illnesses in people around the world. Its portfolio spans conditions such as cancer, bone disease, heart disease, and inflammatory disorders, with well-known treatments including Enbrel, Repatha, Prolia, and many others. Founded in 1980 and based in Thousand Oaks, California, the company works with healthcare professionals across hospitals, clinics, and pharmacies to get its products to patients. Amgen also partners with other leading pharmaceutical companies, including AstraZeneca and BeiGene, to expand the reach and development of its treatments.
